Arbutus Biopharma (ABUS) Capital Expenditures (2013 - 2024)

Arbutus Biopharma (ABUS) posted Capital Expenditures of $86000.0 for Q4 2024, up 8500.0% sequentially from $1000.0 in Q2 2024.

Arbutus Biopharma (ABUS) Capital Expenditures (2013 - 2024) Analysis & Trends

Arbutus Biopharma has reported Capital Expenditures for 12 years, with the latest figure at $86000.0 in Q4 2024.

  • Quarterly Capital Expenditures changed N/A year-over-year to $86000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $86000.0 (down 10.42% YoY) and the FY2024 annual result came in at $182000.0, down 81.94% from the prior year.
  • Capital Expenditures grew to $86000.0 in Q4 2024 per ABUS's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $859000.0 in Q2 2023 and troughed at $1000.0 in Q2 2024.
  • A 5-year average of $161176.5 and a median of $91000.0 in 2022 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2021 and 2024: Capital Expenditures surged 857.58% in 2021, then tumbled 99.88% in 2024.
  • Over 5 years, Capital Expenditures stood at $152000.0 in 2020, then plunged by 61.84% to $58000.0 in 2021, then jumped by 131.03% to $134000.0 in 2022, then sank by 76.12% to $32000.0 in 2023, then soared by 168.75% to $86000.0 in 2024.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $86000.0, $1000.0, and $95000.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.29 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 25.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 572,662.23
7 Royalty Pharma 33.72 Bn 35.84 Bn - 251.02 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 34.68 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 6.26 Mn
10 Arbutus Biopharma 922.95 Mn 830.33 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 86,000.00
Dec 31, 2024 86,000.00
Jun 30, 2024 1,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 95,000.00
Mar 31, 2024 95,000.00
Sep 30, 2023 32,000.00
Sep 30, 2023 32,000.00
Jun 30, 2023 859,000.00
Jun 30, 2023 859,000.00
Mar 31, 2023 117,000.00
Mar 31, 2023 117,000.00
Dec 31, 2022 134,000.00
Dec 31, 2022 134,000.00
Sep 30, 2022 91,000.00
Sep 30, 2022 91,000.00
Jun 30, 2022 212,000.00
Jun 30, 2022 212,000.00
Mar 31, 2022 75,000.00
Mar 31, 2022 75,000.00